Research
-
Collaboration announced between St. Jude Children’s Research Hospital and WFH
The WFH is proud to announce that we will be collaborating with St. Jude Children’s Research Hospital in order to establish a gene therapy clinical...
-
1st WBDR Annual Report to be released in April
The WFH is proud to announce that the 1st World Bleeding Disorders Registry (WBDR) Annual Report will be published mid-April, 2019. The WBDR Annual Report...
-
WBDR: a strong foundation for advocacy
Edwin Goh, Vice-President, Hemophilia Society of Malaysia, opened the, “Measuring and Improving Quality of Care for People with Bleeding Disorders” workshop held in Kuala Lumpur—the...
-
New and Updated Inhibitor Primer: A comprehensive backgrounder
Inhibitors are a serious treatment complication that can occur when people with hemophilia are exposed to clotting factor concentrates. Some patients may have an immune...
-
Head of Nepalese HTC discusses WBDR in video
Bishesh Sharma Poudyal, MD, talks with Donna Coffin, WFH Director, Research & Public Policy about the impact the WFH World Bleeding Disorders Registry (WBDR) is having on the Civil Service...
-
WBDR hits 1,000 patient milestone
The World Federation of Hemophilia (WFH) is happy to announce that on November 28th, 2018 the World Bleeding Disorders Registry (WBDR) reached an important milestone:...
-
Now available: report on the Annual Global Survey 2017
The Report on the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) 2017 is now available in print and online at www.wfh.org/globalsurvey. The report includes...
-
WBDR experience: Civil Service Hospital, Nepal
The WFH World Bleeding Disorders Registry (WBDR) is a web-based data entry system that provides a platform for a network of hemophilia treatment centres (HTCs)...
-
WBDR reaches important milestones
The World Bleeding Disorders Registry (WBDR) provides a global platform for hemophilia treatment centres (HTCs) to collect standardized data on people with hemophilia. The WFH...
-
New gene therapy CME activity: The Science of Gene Therapy for Hemophilia
The World Federation of Hemophilia (WFH) is proud to announce the launch of the next activity in Clinical Advances in Gene Therapy for Hemophilia, an...
